Efficacy and safety of ozanimod in older patients with ulcerative colitis (UC): post hoc analysis of the True North study

被引：0
|
作者：
Chandwe, Kanta [1 ]
Bwakura-Dangarembizi, Mutsa [2 ]
Amadi, Beatrice [1 ]
Tawodzera, Gertrude [2 ]
Murch, Simon [3 ]
Hill, Susan [4 ]
Playford, Ray [5 ,6 ]
VanBuskirk, Kelley [1 ]
Prendergast, Andrew [2 ,7 ]
Kelly, Paul [7 ]
机构：
[1] Univ Zambia, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia
[2] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
[3] Med Sch, Warw kUnivers, Coventry, England
[4] Great Ormond St Hosp Sick Children, London, England
[5] Univ West London, London, England
[6] Univ Coll Cork, Cork, Ireland
[7] Barts & London Queen Mary Univ London, London, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.172
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P100
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [21] Ozanimod Is an Efficacious Oral Therapy After 5-ASA Failure in Immunomodulator- and Biologic-Naive Patients With Ulcerative Colitis: Post Hoc Analysis From True North
    Sands, Bruce E.
    Dignass, Axel
    Irving, Peter
    Chiorean, Michael
    Long, Millie
    Ahmad, Harris A.
    Osterman, Mark
    Petersen, AnnKatrin
    Elegbe, Ayanbola
    Ritter, Timothy E.
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S512 - S513
  • [22] Ozanimod is an efficacious oral therapy after, 5-ASA failure in immunomodulator- and biologic-naive patients with ulcerative colitis: post hoc analysis from True North
    Sands, B. E.
    Dignass, A.
    Irving, P.
    Chiorean, M.
    Long, M.
    Eren, D.
    Ahmad, H. A.
    Osterman, M. T.
    Petersen, A.
    Elegbe, A.
    Ritter, T.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I339 - I340
  • [23] COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Dubinsky, Marla C.
    Betts, Keith
    Eren, Devrim
    Tang, Wenxi
    Yin, Lei
    Gupte-Singh, Komal
    GASTROENTEROLOGY, 2022, 162 (07) : S603 - S603
  • [24] THE EFFECT OF OZANIMOD ON CIRCULATING NEUTROPHILS: RESULTS FROM THE TRUE NORTH STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Harris, Sarah
    Wu, Chun
    Li, Yicong
    Maddux, Rachel
    Hu, Sarah
    Petersen, AnnKatrin
    GASTROENTEROLOGY, 2022, 162 (07) : S973 - S973
  • [25] Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension
    Danese, Silvio
    Panaccione, Remo
    Abreu, Maria T.
    Rubin, David T.
    Ghosh, Subrata
    Dignass, Axel
    Afzali, Anita
    Wolf, Douglas C.
    Chiorean, Michael, V
    Vermeire, Severine
    Jain, Anjali
    Charles, Lorna
    Lawlor, Garrett
    Osterman, Mark T.
    Wu, Hsiuanlin
    Canavan, James B.
    Petersen, Annkatrin
    Colombel, Jean-Frederic
    Regueiro, Miguel
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (02): : 264 - 274
  • [26] Impact of ozanimod on type III collagen turnover biomarkers and the association with ozanimod efficacy in patients with moderately to severely active ulcerative colitis: Results from the phase 3 True North study
    D'Haens, G.
    Maddux, R.
    Wu, C.
    Hu, Y.
    Sands, B. E.
    Mortensen, J. H.
    Zhang, J.
    Petersen, A.
    Harris, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1234 - I1235
  • [27] Impact of Ozanimod on Fecal Calprotectin Levels and the Association With Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 True North Study
    Harris, Sarah
    Maddux, Rachel
    Li, Yicong
    Hu, Sarah
    Wu, Chun
    Petersen, AnnKatrin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S556 - S556
  • [28] Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis Based on Baseline Endoscopic Subscore
    Yarur, Andres J.
    Reinisch, Walter
    Chang, Shannon
    Gecse, Krisztina B.
    Green, Jesse
    Abbatemarco, Arcangelo M.
    Wu, Joseph
    Goetsch, Martina
    Lazin, Krisztina
    Pradeep, Gokul
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1025 - S1026
  • [29] Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
    Riddle, Matthew C.
    Gerstein, Hertzel C.
    Xavier, Denis
    Cushman, William C.
    Leiter, Lawrence A.
    Raubenheimer, Peter J.
    Atisso, Charles M.
    Raha, Sohini
    Varnado, Oralee J.
    Konig, Manige
    Lakshmanan, Mark
    Franek, Edward
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : 1345 - 1351
  • [30] Addressing the safety and efficacy of tofacitinib in ulcerative colitis: A response to the TOFA-UC study
    Shahid, Maryam
    Farid, Isma
    Shahzad, Maryum
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (12) : 2172 - 2173
12345